Loading data for PBE — first visit, this takes a few seconds.
Invesco Biotechnology & G... (PBE)
NYSEArca: PBE
· Prix en temps réel · USD
93.47
-0.75 (-0.80%)
À la clôture : Aug 14, 2026, 1:46 PM
Invesco Biotechnology & Genome ETF (PBE) ETF Price, Holdings & Analysis
-0.80% (1D)
Aucune donnée disponible
| Bid | 93.05 |
| Capitalisation boursière | n/a |
| AUM | 281.95M |
| NAV | 93.86 |
| Bêta | 0.79 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 25.15 |
| Parts en circulation | 4.55M |
| Date de création | Jun 23, 2005 |
| Ask | 93.29 |
| Volume | 159 |
| Moy. Volume (20D) | 22,217 |
| Ouverture | 93.47 |
| Clôture précédente | 94.22 |
| Fourchette du jour | 94.08 - 94.67 |
| Intervalle de 52 semaines | 67.05 - 95.01 |
| Positions | n / A |
| Ratio de frais | 0.58% |
À propos de PBE
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Classe d’actifs Equity
Symbole boursier PBE
Date de création Jun 23, 2005
Fournisseur Invesco
Site web Page d’accueil du fonds
Échange NYSEArca
10 principaux titres 46.14% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Regeneron Pharmaceut... | REGN | 5.47% |
| Amgen Inc | AMGN | 5.22% |
| Caredx Inc | CDNA | 5.03% |
| Vertex Pharmaceutica... | VRTX | 4.98% |
| Royalty Pharma PLC C... | RPRX | 4.93% |
| Biogen Inc | BIIB | 4.78% |
| Gilead Sciences Inc | GILD | 4.43% |
| United Therapeutics ... | UTHR | 4.07% |
| Bio-techne Corp | TECH | 3.73% |
| Illumina Inc | ILMN | 3.50% |
Dividendes Rendement du dividende 1.66%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Jun 22, 2026 | $0.8110 | n / A |
| Mar 23, 2026 | $0.0820 | n / A |
| Dec 22, 2025 | $0.4200 | n / A |
| Sep 22, 2025 | $0.2340 | n / A |
| Jun 23, 2025 | $0.1300 | n / A |
6 jours il y a · Zacks
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?Sector ETF report for PBE
